Skip to main content
. 2018 Aug 28;9(9):851. doi: 10.1038/s41419-018-0937-7

Fig. 3. DSCR8 promotes HCC growth in vivo.

Fig. 3

a Tumor nodes with DSCR8 clones had larger tumor volume (middle panel) and heavier weight (right panel) than these with vectors. b Tumor nodes with shVector-Huh7 had larger tumor volume (middle panel) and heavier weight (right panel) than these with sh-DSCR8. Immunohistochemical staining in the xenografted tissues for Ki-67 (magnification: ×400. Bars: 50 µM.) in tumor nodule tissues showed that DSCR8 clone increased (c), whereas sh-DSCR8 decreased the percentage of Ki-67-positive cells (d). TUNEL assay in the xenografted tissues (magnification: ×400. Bars: 50 µM.) showed that DSCR8 clone reduced the proportion of apoptotic cells (e), whereas sh-DSCR8 increased the percentage (f). Bars: 50 µM. *P < 0.05, **P < 0.01, ***P < 0.001